R97.20 ICD-10-CM Code: Elevated prostate specific antigen [PSA]
Compare with another code for R97.20Check this code on a claim
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Billable · FY2027A valid, specific ICD-10-CM code, reportable for dates of service in FY2027.
What you need to know
Source: CMS/NCHS Official ICD-10-CM tabular notes, quoted. From the CMS/NCHS tabular list for the release in force. A note the category or block publishes applies to this code too, and is marked with where it comes from.
The tabular list publishes no instructional note for this code itself.
Inpatient Payment Groups (MS-DRG)
Potential MS-DRG participation — not a DRG assignment.
MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v44, Appendix B.
- MS-DRG 947 — SIGNS AND SYMPTOMS WITH MCC (MDC 23)
- MS-DRG 948 — SIGNS AND SYMPTOMS WITHOUT MCC (MDC 23)
A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.
Coding context
Guidelines, coding notes, decision aids, relationships (with MS-DRG and CCSR classification), hierarchy, HCC, coverage and the context map: what a coder reaches for after the core. Each section names whether it is official source data, a MedCoder-derived relationship or MedCoder editorial.
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Verify Before Coding
- Questionable admission. The Medicare Code Editor lists this among its questionable-admission codes: reported as the principal diagnosis, it is not usually sufficient justification for an inpatient admission on its own, so it flags the admission as questionable. The code itself remains acceptable as principal.
- Age-restricted: the Medicare Code Editor lists this as an adult (age 15-124) diagnosis; other ages are presumed incorrect.
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
MedCoder-derived relationships — computed from published CMS and AHRQ datasets
Other codes that name R97.20 or its code family, from the CMS ICD-10-CM tabular instructional notes. Tabular-note edges are stored at the code family level that carries each note.
Referenced by 8 Excludes2 notes: R83 — Abnormal findings in cerebrospinal fluid (via R97.-), R83-R89 — Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89) (via R97.-), R84 — Abnormal findings in specimens from respiratory organs and thorax (via R97.-), R85 — Abnormal findings in specimens from digestive organs and abdominal cavity (via R97.-), R86 — Abnormal findings in specimens from male genital organs (via R97.-), R87 — Abnormal findings in specimens from female genital organs (via R97.-), R88 — Abnormal findings in other body fluids and substances (via R97.-), R89 — Abnormal findings in specimens from other organs, systems and tissues (via R97.-).
These codes’ tabular lists name this diagnosis as distinct — both may be reported when both are documented.
MS-DRG Grouper Relationships (FY2027)
Potential MS-DRG participation — not a DRG assignment.
FY2027 MS-DRG: not on the CMS CC/MCC list — as a secondary diagnosis this code does not change MS-DRG severity for that release.
Named in the grouper logic of 2 MS-DRGs: DRG 947 (MDC 23), DRG 948 (MDC 23).
From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.
Clinical classification (AHRQ CCSR):SYM017 — Abnormal findings without diagnosis (default).
Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
Related Codes
Same clinical category (CCSR)
AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical category (Abnormal findings without diagnosis).
R94.120 — Abnormal auditory function study, R94.121 — Abnormal vestibular function study, R94.128 — Abnormal results of other function studies of ear and other special senses, R94.130 — Abnormal response to nerve stimulation, unspecified, R94.131 — Abnormal electromyogram [EMG], R94.138 — Abnormal results of other function studies of peripheral nervous system, R94.2 — Abnormal results of pulmonary function studies, R94.30 — Abnormal result of cardiovascular function study, unspecified, R94.31 — Abnormal electrocardiogram [ECG] [EKG], R94.39 — Abnormal result of other cardiovascular function study, R94.4 — Abnormal results of kidney function studies, R94.5 — Abnormal results of liver function studies, R94.6 — Abnormal results of thyroid function studies, R94.7 — Abnormal results of other endocrine function studies, R94.8 — Abnormal results of function studies of other organs and systems, R97.0 — Elevated carcinoembryonic antigen [CEA], R97.1 — Elevated cancer antigen 125 [CA 125], R97.2 — Elevated prostate specific antigen [PSA], R97.21 — Rising PSA following treatment for malignant neoplasm of prostate, R97.8 — Other abnormal tumor markers, +183 more
Same Index main term, other category
The ICD-10-CM Index to Diseases and Injuries files this code under the main term “Elevated, elevation”; these codes share that main term but sit in a different category of the Tabular List.
I87.8 — Other specified disorders of veins (venous pressure), Q74.0 — Other congenital malformations of upper limb(s), including shoulder girdle (scapula, congenital), Q79.1 — Other congenital malformations of diaphragm (diaphragm, congenital), R03.0 — Elevated blood-pressure reading, without diagnosis of hypertension (blood pressure, reading, no diagnosis of hypertension), R17 — Unspecified jaundice (liver function, test, bilirubin), R50.9 — Fever, unspecified (body temperature), R70.0 — Elevated erythrocyte sedimentation rate (sedimentation rate), R73.01 — Impaired fasting glucose (fasting glucose), R73.02 — Impaired glucose tolerance (oral) (glucose tolerance), R73.9 — Hyperglycemia, unspecified (blood sugar), R74.01 — Elevation of levels of liver transaminase levels (AST), R74.02 — Elevation of levels of lactic acid dehydrogenase [LDH] (lactic acid dehydrogenaselevel), R74.8 — Abnormal levels of other serum enzymes (liver function, test, hepatic enzyme), R76.0 — Raised antibody titer (antibody titer), R76.89 — Other specified abnormal immunological findings in serum (immunoglobulin level), R79.82 — Elevated C-reactive protein (CRP) (C-reactive protein), R79.89 — Other specified abnormal findings of blood chemistry (troponin), R82.5 — Elevated urine levels of drugs, medicaments and biological substances (indoleacetic acid), R94.5 — Abnormal results of liver function studies (liver function, study), R94.8 — Abnormal results of function studies of other organs and systems (basal metabolic rate), +8 more
Lab tests where this diagnosis supports Medicare coverage (NCD)
Medicare's National Coverage Determination (NCD) program lists this diagnosis as medical justification for these lab tests.
Contextual Map
Every relationship of R97.20 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Run R97.20 with these 8 related codes in Claim Check
Hierarchy
- R00-R99 — Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified (R00-R99) (R00-R99)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- R97-R97 — Abnormal tumor markers[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
Referenced by Excludes2 notes
- R83 — Abnormal findings in cerebrospinal fluid[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R83-R89 — Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R84 — Abnormal findings in specimens from respiratory organs and thorax[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R85 — Abnormal findings in specimens from digestive organs and abdominal cavity[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R86 — Abnormal findings in specimens from male genital organs[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R87 — Abnormal findings in specimens from female genital organs[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R88 — Abnormal findings in other body fluids and substances[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- R89 — Abnormal findings in specimens from other organs, systems and tissues[Excludes2](via R97.-): “abnormal tumor markers (R97.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
Clinical classification (CCSR)
- SYM017 — Abnormal findings without diagnosis[CCSR]— AHRQ CCSR for ICD-10-CM Diagnoses (HCUP)
MS-DRG Grouper
- DRG 947 — SIGNS AND SYMPTOMS WITH MCC[MS-DRG]: “SIGNS AND SYMPTOMS WITH MCC (MDC 23)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 948 — SIGNS AND SYMPTOMS WITHOUT MCC[MS-DRG]: “SIGNS AND SYMPTOMS WITHOUT MCC (MDC 23)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
MDC crossing
- MDC 23 — Factors Influencing Health Status and Other Contacts with Health Services[MDC crossing]: “Factors Influencing Health Status and Other Contacts with Health Services — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 1,258 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2027
Index entries
- Elevated, elevation, prostate specific antigen [PSA][Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2027
Nearest codes
- R97 — Abnormal tumor markers[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- R97.0 — Elevated carcinoembryonic antigen [CEA][Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- R97.1 — Elevated cancer antigen 125 [CA 125][Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- R97.2 — Elevated prostate specific antigen [PSA][Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- R97.21 — Rising PSA following treatment for malignant neoplasm of prostate[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- R97.8 — Other abnormal tumor markers[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
Change history
- FY2017 — Added to the code set[Change history]— CMS release files (code change ledger) · icd10cm-fy2017
Reference
Index terms and tables, published questions and FAQ, every source behind this page with its release and checksum, the date-of-service check and the complete change history.
Indexed Clinical Terms (1)
Official source data — entries quoted as published, in the Index’s own lookup phrasing
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code. These are alphabetic-index entries shown as the Index writes them — lookup phrasing, not necessarily the wording of a final diagnosis.
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2027 tabular list, index and tables, effective October 1, 2026 Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v44.0 (October 2026) Release, file and checksum · Publisher’s page
- Inpatient payment groups Official source data
- CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v44 Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder-derived relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder editorial explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources
Labels on this page: Official source data · MedCoder-derived relationship · MedCoder editorial explanation. How to read the labels · All data sources and release dates · CMS coding rules
Cite this page
Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.
MedCoder.ai. "R97.20 — Elevated prostate specific antigen [PSA]." ICD-10-CM FY2027. https://medcoder.ai/icd10/code/r97.20-elevated-prostate-specific-antigen-psa
Change history
- FY2017 — October 1, 2016Added to the code setElevated prostate specific antigen [PSA]FY2017 changes
Nearest Codes in This Family
Official ICD-10-CM classifications closest to R97.20 in its code family, with their registry titles.